Provider
QP67-20 Commercial Pharmacy Benefit Exclusion for DurystaTM, Iluvien®, Retisert® and Yutiq®
Program effective Date: Jul 22, 2020
Documents & Forms Results
Displaying 2301 - 2310 of 3111 results
Provider
QP63-20 MDH Guidance to Support Hospital Patients with Disabilities and Pediatric Patients
Program effective Date: Jul 22, 2020
Provider
QP69-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Risdiplam
Program effective Date: Jul 22, 2020
Provider
QP65-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Satralizumab
Program effective Date: Jul 22, 2020
Provider
QP61-20 Signify Health Virtual Visits for Medicare Advantage and SecureBlue Members
Program effective Date: Jul 08, 2020
Provider
QP58-20 Commercial Pharmacy Benefit Exclusion for Medical Drugs Anjeso™ , Fetroja™ and Potassium Phosphates
Program effective Date: Jul 08, 2020
Provider
QP59-20 MHCP Pharmacy Benefit Exclusion for DurystaTM and Fensolvi®
Program effective Date: Jul 08, 2020
Provider
QP60-20 Commercial Pharmacy Benefit Exclusion for Procysbi® Delayed-Release Granules
Program effective Date: Jul 08, 2020
Provider
P46-20 Genetic/Molecular Lab Test Coding Reimbursement Policy
Program effective Date: Jul 01, 2020
Provider
P52-20 Emergency Department Level of Service Coding Reimbursement Policy
Program effective Date: Jul 01, 2020